Recent Findings in Atrial Fibrillation Described by Researchers from Institute of Health Economics (Cost Effectiveness of Rivaroxaban for Stroke…
Recent Findings in Atrial Fibrillation Described by Researchers from
By a
Our news journalists obtained a quote from the research from the
According to the news editors, the research concluded: "Future health economic studies on novel oral anticoagulants should evaluate the cost effectiveness for secondary stroke prevention and, as clinical data from direct head-to-head comparisons become available, new anticoagulation therapies should be compared against each other."
For more information on this research see: Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation. Pharmacoeconomics, 2015;33(3):271-283. Pharmacoeconomics can be contacted at:
The news correspondents report that additional information may be obtained from A. Mensch,
Keywords for this news article include: Anticoagulants, Drugs,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2015, NewsRx LLC
GoDaddy Celebrates Initial Public Offering and First Day of Trading on the New York Stock Exchange
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News